{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T11:47:47Z","timestamp":1784029667823,"version":"3.55.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s00702-024-02838-3","type":"journal-article","created":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T01:01:36Z","timestamp":1728262896000},"page":"1263-1273","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Diagnostic and therapeutic challenges in PD-associated non-motor symptoms: the roles of neurologists and consultant physicians"],"prefix":"10.1007","volume":"131","author":[{"given":"CW","family":"Ip","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Kassubek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Storch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"T\u00f6nges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Wolz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8574-3297","authenticated-orcid":false,"given":"WH","family":"Jost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,7]]},"reference":[{"issue":"3\u20134","key":"2838_CR1","doi-asserted-by":"publisher","first-page":"74","DOI":"10.61387\/S.2004.34.11","volume":"11","author":"CJ Ahlers","year":"2004","unstructured":"Ahlers CJ, Schaefer GA, Beier KM (2004) Erhebungsinstrumente in Der Klinischen Sexualforschung Und Der Sexualmedizinischen Praxis - Ein \u00dcberblick \u00fcber die Fragebogenentwicklung in Sexualwissenschaft Und Sexualmedizin. Sexuologie: Z f\u00fcr Sexualmedizin Sexualtherapie Und Sexualwissenschaft 11(3\u20134):74\u201397 Assessment instruments in clinical sexology and sexological research - An overview of questionnaires in sexology and sexual medicine","journal-title":"Sexuologie: Z f\u00fcr Sexualmedizin Sexualtherapie Und Sexualwissenschaft"},{"issue":"9","key":"2838_CR2","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1586\/14737175.2015.1077703","volume":"15","author":"U Akbar","year":"2015","unstructured":"Akbar U, Friedman JH (2015) Recognition and treatment of neuropsychiatric disturbances in Parkinson\u2019s disease. Expert Rev Neurother 15(9):1053\u20131065. https:\/\/doi.org\/10.1586\/14737175.2015.1077703","journal-title":"Expert Rev Neurother"},{"issue":"10","key":"2838_CR3","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1136\/jnnp.2003.029413","volume":"75","author":"LM Allcock","year":"2004","unstructured":"Allcock LM, Ullyart K, Kenny RA, Burn DJ (2004) Frequency of orthostatic hypotension in a community based cohort of patients with Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 75(10):1470\u20131471. https:\/\/doi.org\/10.1136\/jnnp.2003.029413","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"2838_CR4","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1097\/mou.0000000000000059","volume":"24","author":"KE Andersson","year":"2014","unstructured":"Andersson KE (2014) The many faces of impaired bladder emptying. Curr Opin Urol 24(4):363\u2013369. https:\/\/doi.org\/10.1097\/mou.0000000000000059","journal-title":"Curr Opin Urol"},{"key":"2838_CR5","doi-asserted-by":"publisher","unstructured":"Archibald NK, Clarke MP, Mosimann UP, Burn DJ (2009) The retina in Parkinson\u2019s disease. Brain 132 (Pt 51128\u20131145. https:\/\/doi.org\/10.1093\/brain\/awp068","DOI":"10.1093\/brain\/awp068"},{"issue":"4","key":"2838_CR6","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/mds.25844","volume":"29","author":"D Berg","year":"2014","unstructured":"Berg D, Postuma RB, Bloem B, Chan P, Dubois B, Gasser T, Goetz CG, Halliday GM, Hardy J, Lang AE, Litvan I, Marek K, Obeso J, Oertel W, Olanow CW, Poewe W, Stern M, Deuschl G (2014) Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson\u2019s disease. Mov Disord 29(4):454\u2013462. https:\/\/doi.org\/10.1002\/mds.25844","journal-title":"Mov Disord"},{"issue":"14","key":"2838_CR7","doi-asserted-by":"publisher","first-page":"e1539","DOI":"10.1212\/wnl.0000000000009214","volume":"94","author":"C Borm","year":"2020","unstructured":"Borm C, Visser F, Werkmann M, de Graaf D, Putz D, Seppi K, Poewe W, Vlaar AMM, Hoyng C, Bloem BR, Theelen T, de Vries NM (2020) Seeing ophthalmologic problems in Parkinson disease: results of a visual impairment questionnaire. Neurology 94(14):e1539\u2013e1547. https:\/\/doi.org\/10.1212\/wnl.0000000000009214","journal-title":"Neurology"},{"issue":"8","key":"2838_CR8","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1002\/mds.26643","volume":"31","author":"MPG Broen","year":"2016","unstructured":"Broen MPG, Narayen NE, Kuijf ML, Dissanayaka NNW, Leentjens AFG (2016) Prevalence of anxiety in Parkinson\u2019s disease: a systematic review and meta-analysis. Mov Disord 31(8):1125\u20131133. https:\/\/doi.org\/10.1002\/mds.26643","journal-title":"Mov Disord"},{"issue":"8","key":"2838_CR9","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s00702-016-1649-8","volume":"124","author":"C Buhmann","year":"2017","unstructured":"Buhmann C, Dogac S, Vettorazzi E, Hidding U, Gerloff C, J\u00fcrgens TP (2017) The impact of Parkinson disease on patients\u2019 sexuality and relationship. J Neural Transm (Vienna) 124(8):983\u2013996. https:\/\/doi.org\/10.1007\/s00702-016-1649-8","journal-title":"J Neural Transm (Vienna)"},{"issue":"s1","key":"2838_CR10","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.3233\/jpd-202069","volume":"10","author":"C Buhmann","year":"2020","unstructured":"Buhmann C, Kassubek J, Jost WH (2020) Management of Pain in Parkinson\u2019s Disease. J Parkinsons Dis 10(s1):S37\u2013s48. https:\/\/doi.org\/10.3233\/jpd-202069","journal-title":"J Parkinsons Dis"},{"key":"2838_CR11","doi-asserted-by":"publisher","unstructured":"Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ (1989) The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28(2):193\u2013213. https:\/\/doi.org\/10.1016\/0165-1781(89)90047-4","DOI":"10.1016\/0165-1781(89)90047-4"},{"issue":"5","key":"2838_CR12","doi-asserted-by":"publisher","first-page":"132","DOI":"10.31083\/j.jin2205132","volume":"22","author":"C Cattaneo","year":"2023","unstructured":"Cattaneo C, Jost WH (2023) Pain in Parkinson\u2019s Disease: pathophysiology, classification and treatment. J Integr Neurosci 22(5):132. https:\/\/doi.org\/10.31083\/j.jin2205132","journal-title":"J Integr Neurosci"},{"issue":"4","key":"2838_CR13","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s12325-018-0687-z","volume":"35","author":"C Cattaneo","year":"2018","unstructured":"Cattaneo C, Kulisevsky J, Tubazio V, Castellani P (2018) Long-term efficacy of Safinamide on Parkinson\u2019s Disease Chronic Pain. Adv Ther 35(4):515\u2013522. https:\/\/doi.org\/10.1007\/s12325-018-0687-z","journal-title":"Adv Ther"},{"issue":"5","key":"2838_CR14","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.3233\/jpd-240063","volume":"14","author":"C De Groote","year":"2024","unstructured":"De Groote C, Dujardin K, Defebvre L, Flinois B, Herlin V, Carri\u00e8re N, Wawrziczny E (2024) Development of a Screening Tool for assessing sexual difficulties among patients with Parkinson\u2019s Disease: the PD-SDS. J Parkinsons Dis 14(5):1015\u20131025. https:\/\/doi.org\/10.3233\/jpd-240063","journal-title":"J Parkinsons Dis"},{"issue":"6","key":"2838_CR15","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nrneurol.2009.62","volume":"5","author":"NJ Diederich","year":"2009","unstructured":"Diederich NJ, F\u00e9nelon G, Stebbins G, Goetz CG (2009) Hallucinations in Parkinson disease. Nat Rev Neurol 5(6):331\u2013342. https:\/\/doi.org\/10.1038\/nrneurol.2009.62","journal-title":"Nat Rev Neurol"},{"key":"2838_CR16","doi-asserted-by":"publisher","unstructured":"Docu Axelerad A, Stroe AZ, Arghir OC, Docu Axelerad D, Gogu AE (2021) Respiratory Dysfunctions in Parkinson\u2019s Disease Patients. Brain Sci 11(5). https:\/\/doi.org\/10.3390\/brainsci11050595","DOI":"10.3390\/brainsci11050595"},{"key":"2838_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.parkreldis.2017.02.014","volume":"40","author":"MS Ekker","year":"2017","unstructured":"Ekker MS, Janssen S, Seppi K, Poewe W, de Vries NM, Theelen T, Nonnekes J, Bloem BR (2017) Ocular and visual disorders in Parkinson\u2019s disease: common but frequently overlooked. Parkinsonism Relat Disord 40:1\u201310. https:\/\/doi.org\/10.1016\/j.parkreldis.2017.02.014","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"2838_CR18","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1002\/mds.27689","volume":"34","author":"AH Evans","year":"2019","unstructured":"Evans AH, Okai D, Weintraub D, Lim S-Y, O\u2019Sullivan SS, Voon V, Krack P, Sampaio C, Post B, Leentjens AFG, Martinez-Martin P, Stebbins GT, Goetz CG, Schrag A, the Members of the International P, Movement Disorder Society Rating Scales Review C (2019) Scales to assess impulsive and compulsive behaviors in Parkinson\u2019s disease: Critique and recommendations. Mov Disord 34(6):791\u2013798. https:\/\/doi.org\/10.1002\/mds.27689","journal-title":"Mov Disord"},{"issue":"4","key":"2838_CR19","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/mds.21875","volume":"23","author":"HH Fernandez","year":"2008","unstructured":"Fernandez HH, Aarsland D, F\u00e9nelon G, Friedman JH, Marsh L, Tr\u00f6ster AI, Poewe W, Rascol O, Sampaio C, Stebbins GT, Goetz CG (2008) Scales to assess psychosis in Parkinson\u2019s disease: Critique and recommendations. Mov Disord 23(4):484\u2013500. https:\/\/doi.org\/10.1002\/mds.21875","journal-title":"Mov Disord"},{"issue":"12","key":"2838_CR20","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.3109\/00207450903222758","volume":"119","author":"HH Fernandez","year":"2009","unstructured":"Fernandez HH, Okun MS, Rodriguez RL, Malaty IA, Romrell J, Sun A, Wu SS, Pillarisetty S, Nyathappa A, Eisenschenk S (2009) Quetiapine improves visual hallucinations in Parkinson disease but not through normalization of sleep architecture: results from a double-blind clinical-polysomnography study. Int J Neurosci 119(12):2196\u20132205. https:\/\/doi.org\/10.3109\/00207450903222758","journal-title":"Int J Neurosci"},{"issue":"13","key":"2838_CR21","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1002\/mds.25223","volume":"27","author":"B Frauscher","year":"2012","unstructured":"Frauscher B, Ehrmann L, Zamarian L, Auer F, Mitterling T, Gabelia D, Brandauer E, Delazer M, Poewe W, H\u00f6gl B (2012) Validation of the Innsbruck REM sleep behavior disorder inventory. Mov Disord 27(13):1673\u20131678. https:\/\/doi.org\/10.1002\/mds.25223","journal-title":"Mov Disord"},{"issue":"3","key":"2838_CR22","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.nbd.2011.12.041","volume":"46","author":"DA Gallagher","year":"2012","unstructured":"Gallagher DA, Schrag A (2012) Psychosis, apathy, depression and anxiety in Parkinson\u2019s disease. Neurobiol Dis 46(3):581\u2013589. https:\/\/doi.org\/10.1016\/j.nbd.2011.12.041","journal-title":"Neurobiol Dis"},{"issue":"8","key":"2838_CR23","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1136\/jnnp-2013-306787","volume":"85","author":"PJ Garcia-Ruiz","year":"2014","unstructured":"Garcia-Ruiz PJ, Martinez Castrillo JC, Alonso-Canovas A, Herranz Barcenas A, Vela L, Sanchez Alonso P, Mata M, Olmedilla Gonzalez N, Mahillo Fernandez I (2014) Impulse control disorder in patients with Parkinson\u2019s disease under dopamine agonist therapy: a multicentre study. J Neurol Neurosurg Psychiatry 85(8):840\u2013844. https:\/\/doi.org\/10.1136\/jnnp-2013-306787","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2838_CR24","doi-asserted-by":"publisher","unstructured":"Goldman JG, Vernaleo BA, Camicioli R, Dahodwala N, Dobkin RD, Ellis T, Galvin JE, Marras C, Edwards J, Fields J, Golden R, Karlawish J, Levin B, Shulman L, Smith G, Tangney C, Thomas CA, Tr\u00f6ster AI, Uc EY, Coyan N, Ellman C, Ellman M, Hoffman C, Hoffman S, Simmonds D (2018) Cognitive impairment in Parkinson\u2019s disease: a report from a multidisciplinary symposium on unmet needs and future directions to maintain cognitive health. NPJ Parkinsons Dis 4(19). https:\/\/doi.org\/10.1038\/s41531-018-0055-3","DOI":"10.1038\/s41531-018-0055-3"},{"issue":"8","key":"2838_CR25","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1212\/wnl.58.8.1247","volume":"58","author":"DS Goldstein","year":"2002","unstructured":"Goldstein DS, Holmes CS, Dendi R, Bruce SR, Li ST (2002) Orthostatic hypotension from sympathetic denervation in Parkinson\u2019s disease. Neurology 58(8):1247\u20131255. https:\/\/doi.org\/10.1212\/wnl.58.8.1247","journal-title":"Neurology"},{"issue":"9","key":"2838_CR26","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1002\/mds.27454","volume":"33","author":"L Guo","year":"2018","unstructured":"Guo L, Normando EM, Shah PA, De Groef L, Cordeiro MF (2018) Oculo-visual abnormalities in Parkinson\u2019s disease: possible value as biomarkers. Mov Disord 33(9):1390\u20131406. https:\/\/doi.org\/10.1002\/mds.27454","journal-title":"Mov Disord"},{"issue":"3","key":"2838_CR27","doi-asserted-by":"publisher","first-page":"e91545","DOI":"10.1371\/journal.pone.0091545","volume":"9","author":"N Hack","year":"2014","unstructured":"Hack N, Fayad SM, Monari EH, Akbar U, Hardwick A, Rodriguez RL, Malaty IA, Romrell J, Wagle Shukla AA, McFarland N, Ward HE, Okun MS (2014) An eight-year clinic experience with clozapine use in a Parkinson\u2019s disease clinic setting. PLoS ONE 9(3):e91545. https:\/\/doi.org\/10.1371\/journal.pone.0091545","journal-title":"PLoS ONE"},{"key":"2838_CR28","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.2147\/ndt.S371641","volume":"19","author":"B Heim","year":"2023","unstructured":"Heim B, Peball M, Krismer F, Djamshidian A, Seppi K (2023) Pimavanserin: a truly effective treatment for Parkinson\u2019s Disease psychosis? A review of interventions. Neuropsychiatr Dis Treat 19:1303\u20131312. https:\/\/doi.org\/10.2147\/ndt.S371641","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"6","key":"2838_CR29","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/mds.21956","volume":"23","author":"MA Hely","year":"2008","unstructured":"Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG (2008) The Sydney multicenter study of Parkinson\u2019s disease: the inevitability of dementia at 20 years. Mov Disord 23(6):837\u2013844. https:\/\/doi.org\/10.1002\/mds.21956","journal-title":"Mov Disord"},{"issue":"1","key":"2838_CR30","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s42466-024-00325-4","volume":"6","author":"G H\u00f6glinger","year":"2024","unstructured":"H\u00f6glinger G, Trenkwalder C (2024) Diagnosis and treatment of Parkinson\u00b4s disease (guideline of the German Society for Neurology). Neurol Res Pract 6(1):30. https:\/\/doi.org\/10.1186\/s42466-024-00325-4","journal-title":"Neurol Res Pract"},{"issue":"9","key":"2838_CR31","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/s1474-4422(24)00170-4","volume":"23","author":"A Iranzo","year":"2024","unstructured":"Iranzo A, Cochen De Cock V, Fantini ML, P\u00e9rez-Carbonell L, Trotti LM (2024) Sleep and sleep disorders in people with Parkinson\u2019s disease. Lancet Neurol 23(9):925\u2013937. https:\/\/doi.org\/10.1016\/s1474-4422(24)00170-4","journal-title":"Lancet Neurol"},{"issue":"4","key":"2838_CR32","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s00702-012-0914-8","volume":"120","author":"WH Jost","year":"2013","unstructured":"Jost WH (2013) Urological problems in Parkinson\u2019s disease: clinical aspects. J Neural Transm (Vienna) 120(4):587\u2013591. https:\/\/doi.org\/10.1007\/s00702-012-0914-8","journal-title":"J Neural Transm (Vienna)"},{"issue":"3","key":"2838_CR33","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.parkreldis.2014.12.016","volume":"21","author":"WH Jost","year":"2015","unstructured":"Jost WH, Augustis S (2015) Severity of orthostatic hypotension in the course of Parkinson\u2019s disease: no correlation with the duration of the disease. Parkinsonism Relat Disord 21(3):314\u2013316. https:\/\/doi.org\/10.1016\/j.parkreldis.2014.12.016","journal-title":"Parkinsonism Relat Disord"},{"issue":"8","key":"2838_CR34","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s00115-013-3754-3","volume":"84","author":"J Kassubek","year":"2013","unstructured":"Kassubek J, Danek A, Del Tredici-Braak K, Greenlee MW, Pinkhardt EH (2013) [The eye as a window to the pathophysiology in Parkinson\u2019s syndromes]. Nervenarzt 84(8):909\u2013917. https:\/\/doi.org\/10.1007\/s00115-013-3754-3","journal-title":"Nervenarzt"},{"issue":"3","key":"2838_CR35","doi-asserted-by":"publisher","first-page":"203","DOI":"10.2165\/11539720-000000000-00000","volume":"25","author":"B Knie","year":"2011","unstructured":"Knie B, Mitra MT, Logishetty K, Chaudhuri KR (2011) Excessive daytime sleepiness in patients with Parkinson\u2019s disease. CNS Drugs 25(3):203\u2013212. https:\/\/doi.org\/10.2165\/11539720-000000000-00000","journal-title":"CNS Drugs"},{"issue":"3","key":"2838_CR36","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1002\/mds.29710","volume":"39","author":"G Mangone","year":"2024","unstructured":"Mangone G, Tosin MHS, Goetz CG, Stebbins GT, Mestre TA (2024) Unveiling Assessment gaps in Parkinson\u2019s Disease psychosis: a scoping review. Mov Disord 39(3):560\u2013570. https:\/\/doi.org\/10.1002\/mds.29710","journal-title":"Mov Disord"},{"issue":"10","key":"2838_CR37","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1007\/s00115-021-01258-y","volume":"93","author":"V Mylius","year":"2022","unstructured":"Mylius V, Perez Lloret S, Brook CS, Kr\u00fcger MT, H\u00e4gele-Link S, Gonzenbach R, Kassubek J, Bohlhalter S, Lefaucheur JP, Timmermann L, K\u00e4gi G, Brugger F, de Ciampi D, M\u00f6ller JC (2022) [The new Parkinson\u2019s disease pain classification system (PD-PCS)]. Nervenarzt 93(10):1019\u20131027. https:\/\/doi.org\/10.1007\/s00115-021-01258-y","journal-title":"Nervenarzt"},{"issue":"1","key":"2838_CR38","doi-asserted-by":"publisher","first-page":"177","DOI":"10.5665\/sleep.3332","volume":"37","author":"AB Neikrug","year":"2014","unstructured":"Neikrug AB, Liu L, Avanzino JA, Maglione JE, Natarajan L, Bradley L, Maugeri A, Corey-Bloom J, Palmer BW, Loredo JS, Ancoli-Israel S (2014) Continuous positive airway pressure improves sleep and daytime sleepiness in patients with Parkinson disease and sleep apnea. Sleep 37(1):177\u2013185. https:\/\/doi.org\/10.5665\/sleep.3332","journal-title":"Sleep"},{"key":"2838_CR39","doi-asserted-by":"publisher","unstructured":"Nieto-Escamez F, Obrero-Gait\u00e1n E, Cort\u00e9s-P\u00e9rez I (2023) Visual Dysfunction in Parkinson\u2019s Disease. Brain Sci 13(8). https:\/\/doi.org\/10.3390\/brainsci13081173","DOI":"10.3390\/brainsci13081173"},{"issue":"3","key":"2838_CR40","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1034\/j.1600-0447.2002.02229.x","volume":"106","author":"FM Nilsson","year":"2002","unstructured":"Nilsson FM, Kessing LV, S\u00f8rensen TM, Andersen PK, Bolwig TG (2002) Major depressive disorder in Parkinson\u2019s disease: a register-based study. Acta Psychiatr Scand 106(3):202\u2013211. https:\/\/doi.org\/10.1034\/j.1600-0447.2002.02229.x","journal-title":"Acta Psychiatr Scand"},{"issue":"5","key":"2838_CR41","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1111\/papr.13352","volume":"24","author":"ACR Nogueira","year":"2024","unstructured":"Nogueira ACR, Pereira KC, Rodrigues VF, Alves DPA, Marques JB, Monteiro ER, Jesus IRT (2024) Pain characterization in patients with Parkinson\u2019s disease. Pain Pract 24(5):786\u2013797. https:\/\/doi.org\/10.1111\/papr.13352","journal-title":"Pain Pract"},{"issue":"4","key":"2838_CR42","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s10072-012-1176-9","volume":"34","author":"YS Oh","year":"2013","unstructured":"Oh YS, Kim JS, Chung YA, You Ie R, Yang DW, Chung SW, Park JW, Kim YI, Lee KS (2013) Orthostatic hypotension, non-dipping and striatal dopamine in Parkinson disease. Neurol Sci 34(4):557\u2013560. https:\/\/doi.org\/10.1007\/s10072-012-1176-9","journal-title":"Neurol Sci"},{"issue":"6","key":"2838_CR43","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1002\/mdc3.12384","volume":"3","author":"S Perez-Lloret","year":"2016","unstructured":"Perez-Lloret S, Ciampi de Andrade D, Lyons KE, Rodr\u00edguez-Bl\u00e1zquez C, Chaudhuri KR, Deuschl G, Cruccu G, Sampaio C, Goetz CG, Schrag A, Martinez-Martin P, Stebbins G (2016) Rating scales for Pain in Parkinson\u2019s Disease: Critique and recommendations. Mov Disord Clin Pract 3(6):527\u2013537. https:\/\/doi.org\/10.1002\/mdc3.12384","journal-title":"Mov Disord Clin Pract"},{"issue":"4","key":"2838_CR44","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.parkreldis.2010.08.004","volume":"17","author":"EH Pinkhardt","year":"2011","unstructured":"Pinkhardt EH, Kassubek J (2011) Ocular motor abnormalities in parkinsonian syndromes. Parkinsonism Relat Disord 17(4):223\u2013230. https:\/\/doi.org\/10.1016\/j.parkreldis.2010.08.004","journal-title":"Parkinsonism Relat Disord"},{"key":"2838_CR45","doi-asserted-by":"publisher","unstructured":"Pitton Rissardo J, Fornari Caprara AL (2023) Cardiac 123I-Metaiodobenzylguanidine (MIBG) Scintigraphy in Parkinson\u2019s Disease: A Comprehensive Review. Brain Sci 13(10). https:\/\/doi.org\/10.3390\/brainsci13101471","DOI":"10.3390\/brainsci13101471"},{"issue":"10","key":"2838_CR46","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1056\/nejm199903113401003","volume":"340","author":"PSG","year":"1999","unstructured":"PSG (1999) Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson\u2019s disease. N Engl J Med 340(10):757\u2013763. https:\/\/doi.org\/10.1056\/nejm199903113401003","journal-title":"N Engl J Med"},{"issue":"3","key":"2838_CR47","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/mds.21116","volume":"22","author":"JM Rabey","year":"2007","unstructured":"Rabey JM, Prokhorov T, Miniovitz A, Dobronevsky E, Klein C (2007) Effect of quetiapine in psychotic Parkinson\u2019s disease patients: a double-blind labeled study of 3 months\u2019 duration. Mov Disord 22(3):313\u2013318. https:\/\/doi.org\/10.1002\/mds.21116","journal-title":"Mov Disord"},{"issue":"12","key":"2838_CR48","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1080\/14737175.2017.1385393","volume":"17","author":"AQ Rana","year":"2017","unstructured":"Rana AQ, Qureshi D, Sabeh W, Mosabbir A, Rahman E, Sarfraz Z, Rana R (2017) Pharmacological therapies for pain in Parkinson\u2019s disease - a review paper. Expert Rev Neurother 17(12):1209\u20131219. https:\/\/doi.org\/10.1080\/14737175.2017.1385393","journal-title":"Expert Rev Neurother"},{"issue":"5","key":"2838_CR49","doi-asserted-by":"publisher","first-page":"e12939","DOI":"10.1111\/jsr.12939","volume":"29","author":"AK Raupach","year":"2020","unstructured":"Raupach AK, Ehgoetz Martens KA, Memarian N, Zhong G, Matar E, Halliday GM, Grunstein R, Lewis SJG (2020) Assessing the role of nocturnal core body temperature dysregulation as a biomarker of neurodegeneration. J Sleep Res 29(5):e12939. https:\/\/doi.org\/10.1111\/jsr.12939","journal-title":"J Sleep Res"},{"issue":"8","key":"2838_CR50","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1002\/mds.21382","volume":"22","author":"B Ravina","year":"2007","unstructured":"Ravina B, Marder K, Fernandez HH, Friedman JH, McDonald W, Murphy D, Aarsland D, Babcock D, Cummings J, Endicott J, Factor S, Galpern W, Lees A, Marsh L, Stacy M, Gwinn-Hardy K, Voon V, Goetz C (2007) Diagnostic criteria for psychosis in Parkinson\u2019s disease: report of an NINDS, NIMH work group. Mov Disord 22(8):1061\u20131068. https:\/\/doi.org\/10.1002\/mds.21382","journal-title":"Mov Disord"},{"issue":"1","key":"2838_CR51","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/mds.22519","volume":"25","author":"R Sakakibara","year":"2010","unstructured":"Sakakibara R, Uchiyama T, Yamanishi T, Kishi M (2010) Genitourinary dysfunction in Parkinson\u2019s disease. Mov Disord 25(1):2\u201312. https:\/\/doi.org\/10.1002\/mds.22519","journal-title":"Mov Disord"},{"issue":"3","key":"2838_CR52","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.baga.2013.05.002","volume":"3","author":"A Sauerbier","year":"2013","unstructured":"Sauerbier A, Chaudhuri RK (2013) Parkinson\u2019s disease and vision. Basal Ganglia 3(3):159\u2013163. https:\/\/doi.org\/10.1016\/j.baga.2013.05.002","journal-title":"Basal Ganglia"},{"key":"2838_CR53","doi-asserted-by":"publisher","unstructured":"Schrag A, Taddei RN (2017) Chapter Twenty - Depression and Anxiety in Parkinson\u2019s Disease. In: Chaudhuri KR, Titova N (eds) International Review of Neurobiology, vol 133. Academic Press, pp 623\u2013655. https:\/\/doi.org\/10.1016\/bs.irn.2017.05.024","DOI":"10.1016\/bs.irn.2017.05.024"},{"issue":"7","key":"2838_CR54","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.3233\/jpd-212749","volume":"12","author":"L Sch\u00fctz","year":"2022","unstructured":"Sch\u00fctz L, Sixel-D\u00f6ring F, Hermann W (2022) Management of Sleep disturbances in Parkinson\u2019s Disease. J Parkinsons Dis 12(7):2029\u20132058. https:\/\/doi.org\/10.3233\/jpd-212749","journal-title":"J Parkinsons Dis"},{"issue":"2","key":"2838_CR55","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/mds.27602","volume":"34","author":"K Seppi","year":"2019","unstructured":"Seppi K, Ray Chaudhuri K, Coelho M, Fox SH, Katzenschlager R, Perez Lloret S, Weintraub D, Sampaio C, the collaborators of the Parkinson\u2019s Disease Update on Non-Motor Symptoms Study Group on behalf of the Movement Disorders Society Evidence-Based Medicine C (2019) Update on treatments for nonmotor symptoms of Parkinson\u2019s disease\u2014an evidence-based medicine review. Mov Disord 34(2):180\u2013198. https:\/\/doi.org\/10.1002\/mds.27602","journal-title":"Mov Disord"},{"issue":"2","key":"2838_CR56","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/mds.27233","volume":"33","author":"M Skorvanek","year":"2018","unstructured":"Skorvanek M, Goldman JG, Jahanshahi M, Marras C, Rektorova I, Schmand B, van Duijn E, Goetz CG, Weintraub D, Stebbins GT, Martinez-Martin P (2018) Global scales for cognitive screening in Parkinson\u2019s disease: Critique and recommendations. Mov Disord 33(2):208\u2013218. https:\/\/doi.org\/10.1002\/mds.27233","journal-title":"Mov Disord"},{"key":"2838_CR57","doi-asserted-by":"publisher","first-page":"897586","DOI":"10.4061\/2011\/897586","volume":"2011","author":"S Sommer","year":"2011","unstructured":"Sommer S, Aral-Becher B, Jost W (2011) Nondipping in Parkinson\u2019s disease. Parkinsons Dis 2011:897586. https:\/\/doi.org\/10.4061\/2011\/897586","journal-title":"Parkinsons Dis"},{"key":"2838_CR58","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jns.2016.09.036","volume":"370","author":"S Strano","year":"2016","unstructured":"Strano S, Fanciulli A, Rizzo M, Marinelli P, Palange P, Tiple D, De Vincentis G, Calcagnini G, Censi F, Meco G, Colosimo C (2016) Cardiovascular dysfunction in untreated Parkinson\u2019s disease: a multi-modality assessment. J Neurol Sci 370:251\u2013255. https:\/\/doi.org\/10.1016\/j.jns.2016.09.036","journal-title":"J Neurol Sci"},{"key":"2838_CR59","doi-asserted-by":"publisher","first-page":"1159821","DOI":"10.3389\/fnhum.2023.1159821","volume":"17","author":"K Suzuki","year":"2023","unstructured":"Suzuki K, Seth AK, Schwartzman DJ (2023) Modelling phenomenological differences in aetiologically distinct visual hallucinations using deep neural networks. Front Hum Neurosci 17:1159821. https:\/\/doi.org\/10.3389\/fnhum.2023.1159821","journal-title":"Front Hum Neurosci"},{"key":"2838_CR60","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-024-02820-z","author":"M Vidailhet","year":"2024","unstructured":"Vidailhet M (2024) Eyes as a window to brain pathology in parkinson\u2019s disease: a narrative review. J Neural Transm (Vienna). https:\/\/doi.org\/10.1007\/s00702-024-02820-z","journal-title":"J Neural Transm (Vienna)"},{"key":"2838_CR61","doi-asserted-by":"publisher","first-page":"e148","DOI":"10.1016\/j.wneu.2024.04.055","volume":"187","author":"Y Wang","year":"2024","unstructured":"Wang Y, Yu L, Mao H, Chen X, Hu P, Ge Y, Liu Y, Zhang J, Cheng H (2024) Deep brain stimulation modulates the visual pathway to improve freezing of Gait in Parkinson\u2019s Disease patients. World Neurosurg 187:e148\u2013e155. https:\/\/doi.org\/10.1016\/j.wneu.2024.04.055","journal-title":"World Neurosurg"},{"issue":"1","key":"2838_CR62","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41531-022-00295-x","volume":"8","author":"T Warnecke","year":"2022","unstructured":"Warnecke T, Sch\u00e4fer KH, Claus I, Del Tredici K, Jost WH (2022) Gastrointestinal involvement in Parkinson\u2019s disease: pathophysiology, diagnosis, and management. NPJ Parkinsons Dis 8(1):31. https:\/\/doi.org\/10.1038\/s41531-022-00295-x","journal-title":"NPJ Parkinsons Dis"},{"issue":"5","key":"2838_CR63","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1001\/archneurol.2010.65","volume":"67","author":"D Weintraub","year":"2010","unstructured":"Weintraub D, Koester J, Potenza MN, Siderowf A, Stacy M, Voon V, Whetteckey J, Wunderlich G, Lang A (2010) Impulse control disorders in parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 67(5):589\u2013595","journal-title":"Arch Neurol"},{"issue":"8","key":"2838_CR64","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/s1474-4422(22)00169-7","volume":"21","author":"W Wieling","year":"2022","unstructured":"Wieling W, Kaufmann H, Claydon VE, van Wijnen VK, Harms MPM, Juraschek SP, Thijs RD (2022) Diagnosis and treatment of orthostatic hypotension. Lancet Neurol 21(8):735\u2013746. https:\/\/doi.org\/10.1016\/s1474-4422(22)00169-7","journal-title":"Lancet Neurol"},{"key":"2838_CR65","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.sleep.2015.12.018","volume":"20","author":"L-Y Zhang","year":"2016","unstructured":"Zhang L-Y, Liu W-Y, Kang W-Y, Yang Q, Wang X-Y, Ding J-Q, Chen S-D, Liu J (2016) Association of rapid eye movement sleep behavior disorder with sleep-disordered breathing in Parkinson\u2019s disease. Sleep Med 20:110\u2013115. https:\/\/doi.org\/10.1016\/j.sleep.2015.12.018","journal-title":"Sleep Med"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-024-02838-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-024-02838-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-024-02838-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T15:11:45Z","timestamp":1729264305000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00702-024-02838-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":65,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["2838"],"URL":"https:\/\/doi.org\/10.1007\/s00702-024-02838-3","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"21 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing financial and non-financial interest concerning the research related to the manuscript. W.J. is or was a consultant and\/or speaker for the following companies: Abbvie, Bial, Desitin, Kyowa Kirin, Stada, UCB, Zambon. A.S. has received funding from the Deutsche Forschungsgemeinschaft (German Research Association) and the Helmholtz-Association outside the present study. He has received honoraria for presentations\/advisory boards\/consultations from Global Kinetics Corporation (manufacturer of the PKG<sup>\u00ae<\/sup>), Esteve, Desitin, Lobsor Pharmaceuticals, STADA, Bial, RG Gesellschaft, Zambon, NovoNordisk and AbbVie outside the present study. He has received royalties from Kohlhammer Verlag and Elsevier Press. He serves as an editorial board member of Stem Cells International.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}